Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Exclusion Criteria

• •Skin pathology in the area of product application;
• •Decompensated Diabetes Mellitus (TBD by the institute together with the sponsor);
• •Immune insufficiency;
• •Current use of the following topical or systemic medications: corticosteroids, immunosuppressants and antihistamines;
• •Skin diseases: vitiligo, psoriasis, atopic dermatitis;
• •Previous reaction to the category of the product tested;
• •Other illnesses or medications that may directly interfere with the study or put the health of the research participant at risk.
• •Have used vaginal moisturizing creams and/or intimate lubricants 5 days before the initial study visit;
• •Have had sexual intercourse at least 48 hours before the initial study visit;
• •Have been diagnosed with a urogenital or vaginal infection in the last 30 days;
• •Have used topical or systemic antibiotics, antifungals, hormone-based creams or treatment for vaginal atrophy in the last 30 days.